Mycenax Biotech
2001
FOUNDED
PUBLIC
STATUS
51-60
EMPLOYEES
4726
STOCK SYMBOL
$0.70
SHARE PRICE
(As of Friday Closing)
Description
Mycenax Biotech Inc is a Taiwan based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company's pipeline products include TuNEX(opinercept - lyophilizate), TuNEX(opinercept - solution), LusiNEX (tocilizumab), and Omalizumab.
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
ROCO
Primary Office
- Research Zhunan Road
- 4th Floor, 50-7 Keyan Road
- Zhunan, Miaoli County 350-53
- Taiwan
+886 03 000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Mycenax Biotech’s full profile, request a free trial.
Mycenax Biotech Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.65 - $0.97 | $89.7M | $0.71 | -$0.07 | 232K | 128M |
Mycenax Biotech Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 75,355 | 79,461 | 75,886 | 90,982 |
| Revenue | 11,153 | 7,008 | 10,452 | 6,191 |
| EBITDA | (5,474) | (6,976) | (4,845) | (3,821) |
| Net Income | (8,655) | (9,097) | (6,179) | (4,891) |
| Total Assets | 47,104 | 36,580 | 44,228 | 42,792 |
| Total Debt | 1,635 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Mycenax Biotech Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Mycenax Biotech‘s full profile, request access.
Request full access to PitchBook